• The Cost & Delivery Institute creates a forum for health care cost- and delivery-focused discussions and contributes to the resources created by the Business Group. The Institute members collaborate through:

• 1 | Semi-annual in-person meetings with agenda items that include an employer roundtable, presentations from industry experts and innovators and benchmarking and networking segments;
• 2 | One virtual meeting per year;
• 3 | Setting the agenda and providing thought leadership at the annual Employer’s Summit on Health Care Cost and Solutions. Institute members receive complimentary passes to the event and are frequently offered speaking roles; and
• 4 | Identifying topics for discussion and resource publications that focus on emerging issues in the areas of plan design, evidence-based benefits, health care delivery innovation and pharmacy.

• Previous and future agenda topics for conferences include:

• 1 | High-cost conditions and clinical innovation
• 2 | Value-based care models
• 3 | Innovation in plan design
• 4 | Data transparency and interoperability
• 5 | Consumer-directed health plans and the evolving role of consumerism
• 6 | Navigating members to appropriate care
• 7 | Cost of specialty medications
• 8 | Drug coverage under the medical plan
• 9 | Behavioral health access and delivery challenges
• 10 | Virtual care
• 11 | Health care quality and access
• 12 | Precision medicine, including genetic testing and gene therapy
• 13 | Women’s health
• 14 | Oncology payment models
• 15 | Health policy and macroeconomic challenges impacting health care consumption
• 16 | Two leadership committees are housed under the Institute:
• Pharmacy Strategy Committee (PSC)
• Evidence-Based Benefit Design Committee (EBDC)
• 17 | Members of the Institute can participate in either or both of these committees and join like-minded peers, experts and patient advocates for a strategic discussion focused on clinical innovation and pharmacy costs.

The Evidence-Based Benefit Design Committee helps identify emerging health care benefit design topics and contributes to the resources created by the Business Group. The committee members collaborate through:

• Semi-annual in person meetings with agenda items including employer roundtables; presentations from industry experts and innovators, benchmarking and networking;
• Two virtual meetings per year featuring an emerging evidence-based topic and member discussion; and
• Publication of resources on emerging topics covering plan design studies, benchmarking, and health conditions that are cost drivers for self-insured members.

The PBC helps drive the pharmacy resources for the Business Group and provides an active member engagement platform. The full committee meets three times each year. Two meetings are held at the Business Group offices in Washington, D.C., and one takes place online via teleconference. In-person meetings dedicate six hours to business; teleconferences last approximately two hours. Minutes of each meeting are kept and distributed to all members of the Committee. In- between meetings, committee members may be asked to review deliverables, participate in webinars and provide expertise.

Previous and ongoing agenda topics include:

• Formulary and utilization management strategy
• Data transparency and interoperability
• Cost and delivery of specialty medications
• Precision medicine, including pharmacogenomics, genetic testing and gene therapy
• Drug and supplement safety
• Waste management
• Couponing/copay assistance
• Adherence
• Site-of-care shift
• Biosimilars
• Opioid misuse and abuse